Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1541 (LINC01541)

Target
LINC01541
Molecular classification
Long non-coding RNA (lncRNA), Intergenic RNA, Other (does not fit receptor/enzyme/transport/protein families)
01

Overview

Long intergenic non-protein coding RNA 1541 (LINC01541) is a human long non-coding RNA gene located on chromosome 18q22.3. It encodes a 3105 bp transcript and is mostly expressed in endometrial tissue. LINC01541 regulates cellular processes by functioning as a molecular sponge for microRNAs, particularly miR-506-5p, thereby influencing the Wnt/β-catenin pathway. Its expression is inversely correlated with miR-506-5p, and it modulates proliferation, migration, invasion, and apoptosis of endometrial stromal cells, notably in the context of estrogen signaling. In endometrial carcinoma, increased LINC01541 expression is correlated with tumor progression and angiogenesis (via VEGFA), suggesting its importance in disease biology and as a potential prognostic marker.

Other names
LINC01541UTAT39Uterine endometrial carcinoma-associated transcript 39RP11-510D19.1ENSG00000260676ENST00000568095NONHSAT059792OTTHUMG00000176200
02

Mechanism of action

Not applicable; however, LINC01541 modulates gene networks by acting as a sponge for miRNAs (notably miR-506-5p), thereby influencing downstream targets such as WIF1 and pathways like Wnt/β-catenin. Its overexpression is associated with suppression of EMT and decreased VEGFA via repression of Wnt/β-catenin signaling.

03

Biological functions

Regulation of gene expression (by acting as a competing endogenous RNA, sponge for microRNAs)Inhibition of epithelial-mesenchymal transition (EMT)Modulation of Wnt/β-catenin signaling pathwayRegulation of cell proliferation, migration, invasion, apoptosis (primarily in endometrial stromal cells)
04

Disease associations

Cancer (primarily endometrial carcinoma, possibly endometriosis)Endometriosis
05

Safety considerations

None reported directly. Challenges could include RNA stability, delivery, and off-target effects for experimental therapies, typical of lncRNA biomarkers.
06

Biomarkers

LINC01541 expression level (proposed as prognostic for endometrial adenocarcinoma and disease progression)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1541 (LINC01541).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1541 (LINC01541).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call